Distinguishing glioma recurrence from treatment effect after radiochemotherapy and immunotherapy.
about
High-grade glioma management and response assessment-recent advances and current challengesPitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy - detecting illusive disease, defining response.Diffusion tensor histogram analysis of pediatric diffuse intrinsic pontine gliomaSingle- and multivoxel proton spectroscopy in pediatric patients with diffuse intrinsic pontine gliomaCellular and vaccine therapeutic approaches for gliomasProton magnetic resonance spectroscopy predicts survival in children with diffuse intrinsic pontine glioma.Glucose-corrected standardized uptake value in the differentiation of high-grade glioma versus post-treatment changes.Parametric Response Mapping of Apparent Diffusion Coefficient as an Imaging Biomarker to Distinguish Pseudoprogression from True Tumor Progression in Peptide-Based Vaccine Therapy for Pediatric Diffuse Intrinsic Pontine Glioma.Pseudoprogression after high-dose busulfan-thiotepa with autologous stem cell transplantation and radiation therapy in children with brain tumors: Impact on survival.Molecular imaging of pediatric brain tumors: comparison of tumor metabolism using ¹⁸F-FDG-PET and MRSI.Accurate differentiation of recurrent gliomas from radiation injury by kinetic analysis of α-11C-methyl-L-tryptophan PET.Histopathological correlates with survival in reoperated glioblastomas.Recent advances in brain tumor-targeted nano-drug delivery systems.Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategiesA Novel Methodology for Applying Multivoxel MR Spectroscopy to Evaluate Convection-Enhanced Drug Delivery in Diffuse Intrinsic Pontine GliomasImplementing preclinical study findings to protocol design: translational studies with alloreactive CTL for gliomas.Pseudoprogression after glioma therapy: an update.Clinical decision making in the era of immunotherapy for high grade-glioma: report of four cases.Imaging in neuro-oncology.Effective immunotherapy of rat glioblastoma with prolonged intratumoral delivery of exogenous heat shock protein Hsp70.Preclinical MRI: Studies of the irradiated brain
P2860
Q26740664-9451A316-C350-487F-B4D1-CBA64423AAB5Q30907831-E7FBD6C8-02B6-4B3D-87A2-CCF5A02F833EQ33810394-1FB88068-7AF6-4FFE-B9A0-3D4C23BD9D27Q34207681-2D70A3D9-8D7C-4FF4-997D-ED407396DD38Q34243550-8C9C317B-02F2-4B6F-AC2D-F9FACE4F09A1Q35421487-488558D9-BD9B-4A40-BF08-C8250D89B503Q35577661-4568217D-8B8A-47A3-8FFC-CBFB3F40A5CEQ36279602-B842199F-6FCE-4D2A-AA35-62DBDD36C722Q36344743-62E373F6-DB44-42C5-8548-967E37608ED4Q36352051-5386C427-C5ED-4452-8C1D-A7E2214DAE3CQ37182922-B014A320-3195-4C28-893A-6B307375B315Q37714899-AD07D288-4EB2-4F0C-A5E6-55735C49A0E8Q38011262-B2E6DA28-81AA-4495-A6E9-7C88D7997FA7Q38074638-24B4A943-9828-4F3A-8319-8D18479C95C9Q39950465-0BA54276-AD0C-4DF4-BB3C-1EBF45D589B8Q40985735-684E40B1-7581-4259-9EC7-1ED166ED041AQ48130815-928F3809-8D54-4282-9DB0-41D322D4C933Q52681027-9BB1CE62-F283-43D6-921F-957414F269ADQ54973707-A83D62A0-DDD4-4313-B7EE-F5CA7E44CC03Q55461040-D401B912-1FE3-4DF1-936F-E5A769B4EF74Q57178476-809F299D-E041-4B9D-95C2-FF6086661AF0
P2860
Distinguishing glioma recurrence from treatment effect after radiochemotherapy and immunotherapy.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Distinguishing glioma recurren ...... hemotherapy and immunotherapy.
@ast
Distinguishing glioma recurren ...... hemotherapy and immunotherapy.
@en
Distinguishing glioma recurren ...... hemotherapy and immunotherapy.
@nl
type
label
Distinguishing glioma recurren ...... hemotherapy and immunotherapy.
@ast
Distinguishing glioma recurren ...... hemotherapy and immunotherapy.
@en
Distinguishing glioma recurren ...... hemotherapy and immunotherapy.
@nl
prefLabel
Distinguishing glioma recurren ...... hemotherapy and immunotherapy.
@ast
Distinguishing glioma recurren ...... hemotherapy and immunotherapy.
@en
Distinguishing glioma recurren ...... hemotherapy and immunotherapy.
@nl
P2093
P1476
Distinguishing glioma recurren ...... hemotherapy and immunotherapy.
@en
P2093
Andrew T Parsa
Nancy G Huh
Seunggu J Han
Zachary A Smith
P304
P356
10.1016/J.NEC.2009.08.003
P50
P577
2010-01-01T00:00:00Z